Premium
Significant responses to platinum‐based chemotherapy in renal medullary carcinoma
Author(s) -
Strouse John J.,
Spevak Melissa,
Mack A. Kyle,
Arceci Robert J.,
Small Donald,
Loeb David M.
Publication year - 2005
Publication title -
pediatric blood and cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.116
H-Index - 105
eISSN - 1545-5017
pISSN - 1545-5009
DOI - 10.1002/pbc.20292
Subject(s) - medicine , carboplatin , gemcitabine , cisplatin , chemotherapy , oncology , medullary cavity , paclitaxel , combination chemotherapy , disease
Most patients with renal medullary carcinoma (RMC) have advanced disease at presentation and rarely respond to radiation or chemotherapy. We describe two adolescents with metastatic disease who had significant responses to cisplatin or carboplatin in combination with gemcitabine and paclitaxel. © 2004 Wiley‐Liss, Inc.